[THE USE OF 6-ALPHA-METHYL-17-ALPHA-ACETOXYPROGESTERONE (M.A.P.) IN OBSTETRICS IN ITS REPERCUSSIONS ON FETUSES OF THE FEMALE SEX].
D000028:Abortion, Induced; D000022:Abortion, Spontaneous; D000033:Abortion, Threatened; D035843:Biomedical Research; D005260:Female; D005333:Fetus; D006801:Humans; D007231:Infant, Newborn; D008525:Medroxyprogesterone; D009774:Obstetrics; D010600:Pharmacology; D011247:Pregnancy; D014116:Toxicology; D014770:Virilism
D008525:Medroxyprogesterone
ABORTION, THREATENED; CLINICAL RESEARCH; FETUS; INFANT, NEWBORN; MEDROXYPROGESTERONE; PHARMACOLOGY; PREGNANCY; TOXICOLOGIC REPORT; VIRILISM
L'IMPIEGO 6-ALPHA-METIL-17-ALPHA-ACETOSSIPROGESTERONE (M.A.P.) IN OSTETRICIA NEI SUOI RIFLESSI SUI FETI DI SESSO FEMMINILE.